- Public Comps
- HBM Healthcare Investments
HBM Healthcare Investments Valuation Multiples
Discover HBM Healthcare Investments' revenue and EBITDA valuation multiples, acquisitions, and investment history, alongside public comparables like FIBRA Macquarie, BWP Gr, Storskogen Group, Grupo Bolivar and more.
HBM Healthcare Investments Overview
About HBM Healthcare Investments
HBM Healthcare Investments Ltd is a Switzerland-based holding company. The firm actively invests in the human medicine, biotechnology, medical technology, and diagnostics sectors and related areas. The company holds and manages an international portfolio of companies.
Founded
2001
HQ

Employees
1
Website
Sectors
Financials (LTM)
EV
$2.1B
Valuation Multiples
Start free trialHBM Healthcare Investments Financials
HBM Healthcare Investments reported last 12-month revenue of $102M.
In the same LTM period, HBM Healthcare Investments generated $347M in net income.
Revenue (LTM)
HBM Healthcare Investments P&L
In the most recent fiscal year, HBM Healthcare Investments reported revenue of $337M and net income of $334M.
HBM Healthcare Investments is profitable as of last fiscal year, with net margin of 99%.
Financial data powered by Morningstar, Inc.
HBM Healthcare Investments Stock Performance
HBM Healthcare Investments has current market cap of $2B, and enterprise value of $2.1B.
Market Cap Evolution
HBM Healthcare Investments' stock price is $306.74.
HBM Healthcare Investments share price increased by 33.1% in the last year.
HBM Healthcare Investments has an EPS (earnings per share) of $51.21.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2.1B | $2B | 0.0% | - | 5.0% | 33.1% | $51.21 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialHBM Healthcare Investments Valuation Multiples
HBM Healthcare Investments trades at 20.8x EV/Revenue multiple.
EV / Revenue (LTM)
HBM Healthcare Investments Financial Valuation Multiples
As of September 3, 2026, HBM Healthcare Investments has market cap of $2B and EV of $2.1B.
HBM Healthcare Investments has a P/E ratio of 5.8x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified HBM Healthcare Investments Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


HBM Healthcare Investments Margins & Growth Rates
In the most recent fiscal year, HBM Healthcare Investments reported net margin of 99%.
HBM Healthcare Investments Margins
HBM Healthcare Investments Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
HBM Healthcare Investments Operational KPIs
HBM Healthcare Investments' revenue per employee in the last FY averaged $337.4M, while opex per employee averaged $3.2M for the same period.
Data powered by FactSet, Inc. and Morningstar, Inc.
HBM Healthcare Investments Competitors
HBM Healthcare Investments competitors include FIBRA Macquarie, BWP Gr, Storskogen Group, Grupo Bolivar, Ashmore Group, L1 Long Short Fund, Tri-Continental, Fortress Real Estate Investments, Generation Capital and IBI Investment House.
Most HBM Healthcare Investments public comparables operate across Asset Management.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 11.0x | 10.8x | (46.4x) | 14.4x | |||
| 17.0x | 16.9x | 7.9x | 19.3x | |||
| 0.9x | 0.8x | 7.0x | 6.6x | |||
| 1.2x | - | - | - | |||
| 5.1x | 5.2x | 10.4x | 15.8x | |||
| 10.3x | - | - | - | |||
| 7.6x | - | - | - | |||
| 8.6x | 10.2x | 9.6x | 13.0x | |||
This data is available for Pro users. Sign up to see all HBM Healthcare Investments competitors and their valuation data. Start Free Trial | ||||||
Acquisitions by HBM Healthcare Investments
HBM Healthcare Investments has acquired 1 company to date.
Last acquisition by HBM Healthcare Investments was on May 10th 2018. HBM Healthcare Investments acquired ARMO BioSciences for $1.6B (EV/Revenue multiple available to Pro users).
Latest Acquisitions by HBM Healthcare Investments
| Description | - |
| HQ Country | |
| HQ City | San Francisco, CA |
| Deal Date | 10 May 2018 |
| Valuation | $1.6B |
| EV/Revenue | |
| EV/EBITDA | |
This data is available for Pro users. Sign up to see all HBM Healthcare Investments acquisitions and their M&A valuation multiples. Start Free Trial | |
Investments by HBM Healthcare Investments
HBM Healthcare Investments has invested in 98 companies to date.
Latest investment by HBM Healthcare Investments was on August 23rd 2026. HBM Healthcare Investments invested in Shape Memory Medical in their $10M Undisclosed stage round (EV/Revenue multiple available to Pro users).
Latest Investments by HBM Healthcare Investments
| Description | Shape Memory Medical is a Santa Clara, California-based medical device firm commercializing shape memory polymer foam technology for vascular applications. Originating from research at Texas A&M University and Lawrence Livermore National Laboratory, its FDA-cleared devices target peripheral, cardiovascular, and neurovascular markets. | Fore Biotherapeutics is a precision oncology biotech headquartered in Cambridge, Massachusetts. The company develops small-molecule therapies targeting undruggable mutations in RAS, PI3K, and MTAP pathways using functional genomics screening. Its lead program advances toward clinical trials for pancreatic and lung cancers. Fore Bio collaborates with academic labs and raised Series A funding in 2023. | Dren Bio is a San Francisco-based biotechnology company engineering proteins to deplete disease-causing cells and aggregates. It advances multiple therapeutic projects as standalone assets through drenbio.com. | Lycia Therapeutics is a South San Francisco-based biotechnology firm advancing lysosomal targeting chimeras platform to degrade disease-causing extracellular proteins. Its LYTAC technology addresses targets inaccessible to traditional drugs, developing therapies for neurodegenerative disorders, cancer, and autoimmune diseases. Founded in 2020, the company raised significant venture funding from investors like Versant Ventures and The Column Group. | |
| HQ Country | |||||
| HQ City | San Jose, CA | Philadelphia, PA | San Francisco, CA | San Francisco, CA | |
| Deal Date | 23 Aug 2026 | 6 Jul 2026 | 30 Jun 2026 | 24 Jun 2026 | |
| Round | Undisclosed stage | Series D | Undisclosed stage | Series D | |
| Raised | $10M | $67M | undisclosed | $75M | |
| Investors | Heal Venture Lab; HBM Healthcare Investments; August Global Partners; Taiwania Capital Management Corporation; Wexford Capital; Earlybird VC | Novartis Venture Fund; Wellington Management; Axil Capital; LG Technology Ventures; HBM Healthcare Investments; Cormorant Asset Management; SymBiosis; 3B Future Health Fund; SR One; Primer Ventures; OrbiMed; Samsung Securities | HBM Healthcare Investments | BrandywineGLOBAL; RTW Investments; Balyasny Asset Management; HBM Healthcare Investments; Invus; Eli Lilly; Adage Capital Management; OrbiMed; Janus Henderson Investors; Venrock Healthcare Capital Partners | |
| Valuation | undisclosed | undisclosed | undisclosed | undisclosed | |
| EV/Revenue | |||||
| EV/EBITDA | |||||
This data is available for Pro users. Sign up to see all HBM Healthcare Investments investments and their VC round multiples. Start Free Trial | |||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout HBM Healthcare Investments
| When was HBM Healthcare Investments founded? | HBM Healthcare Investments was founded in 2001. |
| Where is HBM Healthcare Investments headquartered? | HBM Healthcare Investments is headquartered in Switzerland. |
| How many employees does HBM Healthcare Investments have? | As of today, HBM Healthcare Investments has over 1 employees. |
| Is HBM Healthcare Investments publicly listed? | Yes, HBM Healthcare Investments is a public company listed on SIX Swiss Exchange. |
| What is the stock symbol of HBM Healthcare Investments? | HBM Healthcare Investments trades under HBMN ticker. |
| Who are competitors of HBM Healthcare Investments? | HBM Healthcare Investments main competitors include FIBRA Macquarie, BWP Gr, Storskogen Group, Grupo Bolivar, Ashmore Group, L1 Long Short Fund, Tri-Continental, Fortress Real Estate Investments, Generation Capital, IBI Investment House. |
| What is the current market cap of HBM Healthcare Investments? | HBM Healthcare Investments' current market cap is $2B. |
| What is the current revenue of HBM Healthcare Investments? | HBM Healthcare Investments' last 12 months revenue is $102M. |
| What is the current EV/Revenue multiple of HBM Healthcare Investments? | Current revenue multiple of HBM Healthcare Investments is 20.8x. |
| What is the current net income of HBM Healthcare Investments? | HBM Healthcare Investments' last 12 months net income is $347M. |
| How many companies HBM Healthcare Investments has acquired to date? | As of September 2026, HBM Healthcare Investments has acquired 1 company. |
| What was the largest acquisition by HBM Healthcare Investments? | $1.6B acquisition of ARMO BioSciences on 10th May 2018 was the largest M&A HBM Healthcare Investments has done to date. |
| What companies HBM Healthcare Investments acquired? | HBM Healthcare Investments acquired ARMO BioSciences. |
| In how many companies HBM Healthcare Investments has invested to date? | As of September 2026, HBM Healthcare Investments has invested in 98 companies. |
| What was the last HBM Healthcare Investments investment? | On 23rd August 2026 HBM Healthcare Investments invested in Shape Memory Medical, participating in a $10M Undisclosed stage round, alongside Heal Venture Lab, August Global Partners, Taiwania Capital Management Corporation, Wexford Capital, and Earlybird VC. |
| In what companies HBM Healthcare Investments invested in? | HBM Healthcare Investments invested in Everest Medicines, Freenome, Corxel Pharmaceuticals, Harmony Biosciences, Alumis, CellCentric, Odyssey Therapeutics, NiKang Therapeutics, Ambrx, Upstream Bio, ADARx Pharmaceuticals, Valo Health, Electra Therapeutics, Bluejay Therapeutics, Nuance Biotech, SK Biopharmaceuticals, Ignis Therapeutics, FogPharma, Karius, ArriVent BioPharma, and 78 other companies. |
See public comps similar to HBM Healthcare Investments
Lists including HBM Healthcare Investments
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.





